World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
99
Citations
54583
World Ranking
767
National Ranking
424

Research.com Recognitions

  • 2020 - Member of the National Academy of Medicine (NAM)
  • 2019 - Sedgwick Memorial Medal, American Public Health Association
  • 2019 - Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology
  • 2015 - Metlife Foundation Award for Medical Research in Alzheimer's Disease

Overview

Randall J. Bateman is affiliated with Washington University in St. Louis in the United States. The primary focus of their research is within the field of Medicine, with notable contributions across various subfields including Physiology, Psychiatry and Mental Health, Molecular Biology, Neurology, and Cognitive Neuroscience.

Their work extensively covers key topics related to Alzheimer's disease and related neurodegenerative disorders. Major research themes include:

  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Functional Brain Connectivity Studies
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Bioinformatics and Genomic Networks
  • Health Systems, Economic Evaluations, Quality of Life
  • Cholinesterase and Neurodegenerative Diseases

Randall J. Bateman has a substantial publication record, with a high volume of papers appearing in prominent venues such as:

  • Alzheimer s & Dementia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Medicine
  • Brain
  • Alzheimer s Research & Therapy

Several frequent coauthors have contributed to their research collaborations, including:

  • Tammie L.S. Benzinger
  • Eric McDade
  • Brian A. Gordon
  • John C. Morris
  • Carlos Cruchaga

Some recent papers by Randall J. Bateman include:

  • Lecanemab in Early Alzheimer's Disease, 2022, New England Journal of Medicine
  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease, 2020, Nature Medicine
  • Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease, 2021, JAMA Neurology
  • Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease, 2022, Brain
  • Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease, 2020, The Journal of Experimental Medicine

The scientist has received several awards recognizing their contributions, including:

  • Member of the National Academy of Medicine (NAM), 2020
  • Sedgwick Memorial Medal, American Public Health Association, 2019
  • Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases, American Academy of Neurology, 2019
  • Metlife Foundation Award for Medical Research in Alzheimer's Disease, 2015

Best Publications

  • Lecanemab in Early Alzheimer's Disease.

    Unknown

  • Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease

    Randall J. Bateman;Chengjie Xiong;Tammie L.S. Benzinger;Anne M. Fagan

  • Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

    Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel

  • Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

    Kwasi G. Mawuenyega;Wendy Sigurdson;Vitaliy Ovod;Ling Munsell

  • Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle

    Jae Eun Kang;Miranda M. Lim;Randall J. Bateman;James J. Lee

  • Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

    Joseph M. Castellano;Jungsu Kim;Floy R. Stewart;Hong Jiang

  • Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease

    Oliver Preische;Oliver Preische;Stephanie A. Schultz;Anja Apel;Anja Apel;Jens Kuhle

  • High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.

    Suzanne E. Schindler;James G. Bollinger;Vitaliy Ovod;Kwasi G. Mawuenyega

  • Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.

    Randall J Bateman;Ling Y Munsell;John C Morris;Robert Swarm

  • Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

    Randall J Bateman;Paul S Aisen;Bart De Strooper;Bart De Strooper;Nick C Fox

  • Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

    Brian A Gordon;Tyler M Blazey;Yi Su;Amrita Hari-Raj

  • A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.

    Nicolas R Barthélemy;Yan Li;Nelly Joseph-Mathurin;Brian A Gordon

  • Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer’s Disease Pathology

    Jee Hoon Roh;Yafei Huang;Adam W. Bero;Tom Kasten

  • Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis

    Vitaliy Ovod;Kara N. Ramsey;Kwasi G. Mawuenyega;Jim G. Bollinger

  • Tau Kinetics in Neurons and the Human Central Nervous System

    Chihiro Sato;Nicolas R. Barthélemy;Kwasi G. Mawuenyega;Bruce W. Patterson

  • White Matter Hyperintensities Are a Core Feature of Alzheimer's Disease: Evidence from the Dominantly Inherited Alzheimer Network

    Seonjoo Lee;Fawad Viqar;Fawad Viqar;Molly E. Zimmerman;Molly E. Zimmerman;Atul Narkhede

  • Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

    Unknown

  • Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis

    Davis C. Ryman;Natalia Acosta-Baena;Paul S. Aisen;Thomas Bird

  • CLINICAL AND BIOMARKER CHANGES IN DOMINANTLY INHERITED ALZHEIMER'S DISEASE

    PR Schofield;RJ Bateman;C Xiong;Tls Benzinger

  • Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.

    Shorena Janelidze;Charlotte E. Teunissen;Henrik Zetterberg;Henrik Zetterberg;José Antonio Allué

  • A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.

    Randall J. Bateman;Eric R. Siemers;Kwasi G. Mawuenyega;Guolin Wen

  • Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

    R.J. Bateman;P.S. Aisen;B. De Strooper;N.C. Fox

  • White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

    Seonjoo Lee;Fawad Viqar;Molly E. Zimmerman;Atul Narkhede

Frequent Co-Authors

John C. Morris
John C. Morris Washington University in St. Louis
Tammie L.S. Benzinger
Tammie L.S. Benzinger Washington University in St. Louis
Peter R. Schofield
Peter R. Schofield Neuroscience Research Australia
Alison Goate
Alison Goate Icahn School of Medicine at Mount Sinai
Jasmeer P. Chhatwal
Jasmeer P. Chhatwal Harvard University
David M. Holtzman
David M. Holtzman Washington University in St. Louis
Reisa A. Sperling
Reisa A. Sperling Brigham and Women's Hospital
Martin N. Rossor
Martin N. Rossor University College London
Clifford R. Jack
Clifford R. Jack Mayo Clinic
Daniel S. Marcus
Daniel S. Marcus Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Neuroscience doesn’t need to follow a traditional academic route. Many students now opt for a bachelor degree online in 2 years, gaining flexibility and accelerating their entry into the workforce. These programs can be ideal for those eager to start their careers or switch fields quickly.

Given the competitive nature of science and healthcare roles, it’s important to consider the best degree in the world for long-term success. Some degrees connect directly to the highest paying jobs in fields like technology, pharmaceuticals, and medical research.

Affordability is another vital factor. Students looking to minimize debt and maximize value should research the cheapest online college options that also accept federal aid. With so many respected and affordable online programs now available, mapping a successful, well-paid career in neuroscience and beyond is more accessible than ever.

Best Scientists Citing Randall J. Bateman

Trending Scientists